HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Elisa Fagnani Selected Research

NF023

10/2020Computational and Experimental Characterization of NF023, A Candidate Anticancer Compound Inhibiting cIAP2/TRAF2 Assembly.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Elisa Fagnani Research Topics

Disease

1Cutis Laxa
01/2021
1Inborn Genetic Diseases (Disease, Hereditary)
01/2021
1Amyloidosis
01/2021
1Polyneuropathies (Polyneuropathy)
01/2021
1Neoplasms (Cancer)
10/2020

Drug/Important Bio-Agent (IBA)

2Proteins (Proteins, Gene)FDA Link
01/2021 - 10/2020
1Inhibitor of Apoptosis ProteinsIBA
10/2020
1Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
10/2020
1TNF Receptor-Associated Factor 2 (TRAF2)IBA
10/2020
1NF023IBA
10/2020